for hers compounded semaglutide Despite the Stigma, Hims & Isn't Backing Away From Weight-Loss Drugs Hims? Hers? It's Novo Nordisk's

Pharmacies making or distributing compounded GLP-1s use active pharmaceutical ingredients (APIs) that often are not evaluated or inspected by the FDA

A 2021 study published in the New England Journal of Medicine (Wilding et al., NEJM, 2021) found that semaglutide 2.4 mg produced an average weight loss of approximately 14.9% of body weight over 68 weeks in adults with obesity, compared to 2.4% in the placebo group

The 12 monthly cost looks cheap compared to a prescription, but spending money on something that doesn't work isn't a saving

3/ 503A compounding pharmacies vs

GLP-1s also act on the central nervous system, particularly the brainstem and hypothalamus, where it regulates satiety and appetite

Westermark, P., Andersson, A